# Study of Human Epidermal Growth Factor Receptor 2 (HER2) Expression in Participants With Early/Metastatic Breast Cancer in Saudi Arabia

> **NCT02954471** · — · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 351 (actual)

## Conditions studied

- Breast Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02954471
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10-21
- **Primary completion:** 2019-09-17
- **Final completion:** 2019-09-17
- **Target enrollment:** 351 (ACTUAL)
- **Last updated:** 2019-09-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02954471

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02954471, "Study of Human Epidermal Growth Factor Receptor 2 (HER2) Expression in Participants With Early/Metastatic Breast Cancer in Saudi Arabia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02954471. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*